Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Journal of Experimental & Clinical Cancer Research : CR
|
August 6, 2024
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer
Muhlis Akman, Ciro Monteleone, Gabriella Doronzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
Ramona Rotolo, Valeria Leuci, Chiara Donini, et al.
Diagnostics (Basel, Switzerland)
|
July 27, 2022
Diagnostics of <i>BAP1</i>-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience
Marika Sculco, Marta La Vecchia, Anna Aspesi, et al.
Neurology and Therapy
|
September 19, 2025
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty
Gina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, et al.
Journal of Translational Medicine
|
March 11, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma
Francesca Jacobs, Lorenzo Manganaro, Lorenzo D'Ambrosio, et al.
Multiple Sclerosis and Related Disorders
|
May 8, 2024
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab
Elisabetta Signoriello, Alessio Signori, Giacomo Lus, et al.
CNS Drugs
|
May 29, 2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study
Giovanni Novi, Francesca Bovis, Chiara Sciolla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2024
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
Francesco Passiglia, Angela Listì, Paolo Bironzo, et al.
JACC. Advances
|
June 30, 2026
Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights From the PROLONG Registry
Carlo Gaspardone, Daniela Trabattoni, Daniele O d'Atri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 12, 2024
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy
Doriana Landi, Silvia Bartolomeo, Francesca Bovis, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Journal of Experimental & Clinical Cancer Research : CR
|
August 6, 2024
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer
Muhlis Akman, Ciro Monteleone, Gabriella Doronzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
Ramona Rotolo, Valeria Leuci, Chiara Donini, et al.
Diagnostics (Basel, Switzerland)
|
July 27, 2022
Diagnostics of <i>BAP1</i>-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience
Marika Sculco, Marta La Vecchia, Anna Aspesi, et al.
Neurology and Therapy
|
September 19, 2025
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty
Gina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, et al.
Journal of Translational Medicine
|
March 11, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma
Francesca Jacobs, Lorenzo Manganaro, Lorenzo D'Ambrosio, et al.
Multiple Sclerosis and Related Disorders
|
May 8, 2024
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab
Elisabetta Signoriello, Alessio Signori, Giacomo Lus, et al.
CNS Drugs
|
May 29, 2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study
Giovanni Novi, Francesca Bovis, Chiara Sciolla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2024
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
Francesco Passiglia, Angela Listì, Paolo Bironzo, et al.
JACC. Advances
|
June 30, 2026
Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights From the PROLONG Registry
Carlo Gaspardone, Daniela Trabattoni, Daniele O d'Atri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 12, 2024
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy
Doriana Landi, Silvia Bartolomeo, Francesca Bovis, et al.
Page
of 7